Skip to content

Ganciclovir

Cytovene, Ganzyk-rtu, Vitrasert, Zirgan (ganciclovir) is a small molecule pharmaceutical. Ganciclovir was first approved as Cytovene on 1994-12-22. It is used to treat aids-related opportunistic infections, cytomegalovirus infections, and cytomegalovirus retinitis in the USA. Cytovene iv's patent is valid until 2034-09-02 (FDA).
Trade Name Cytovene, Ganzyk-rtu, Vitrasert, Zirgan
Common Name Ganciclovir
Indication aids-related opportunistic infections, cytomegalovirus infections, cytomegalovirus retinitis
Drug Class Antivirals: antivirals (acyclovir type)
Ganciclovir
Get full access now